-
Notable Analyst Rating Changes 05/05: (ARIA) (CRM) (DIS) Upgraded; (SINA) (SFY) (HP) Downgraded
-
Pre-Open Stock Movers 3/25: (GALT) (ECYT) (RAX) Higher; (IDN) (HIMX) (GIII) Lower (more...)
-
Notable Analyst Rating Changes 02/26: (LNKD) (RRC) (ARIA) Upgraded; (PSA) (NIHD) (HUM) Downgraded
-
ARIAD Pharma (ARIA) Plans to Present at RBC Capital Markets Healthcare Conference
-
Pre-Open Stock Movers 2/7: (IMN) (LQDT) (EXPE) Higher; (FWM) (ELON) (LNKD) Lower (more...)
-
Notable Analyst Rating Changes 12/10: (CELG) (GERN) (ARIA) Upgraded; (DGX) (HME) (CHL) Downgraded
-
Pre-Open Stock Movers 11/01: (DRAD) (GDOT) (FRO) Higher; (BODY) (HTCH) (ELLI) Lower (more...)
-
Market Wrap: Acitivity Picks Up in Chicago; A Bigger Clothing Deal?; Twitter IPO Coming Soon
-
RBC Capital Downgrades ARIAD Pharmaceuticals (ARIA) to Sector Perform
-
Notable Analyst Rating Changes 10/10: (DFS) (HPQ) (SSYS) Upgraded; (ARIA) (RT) (HUBG) Downgraded
-
Notable Analyst Rating Changes 09/30: (BBRY) (CIT) (CMG) Upgraded; (IP) (ICI) (ARIA) Downgraded
-
RBC Reiterates Outperform Rating on Ariad (ARIA)
-
April Data on ARIAD's (ARIA) Iclusig Supports Bullish Thesis - RBC
-
ARIAD Pharma (ARIA) Prices 15.3M Offering at $19.60/Share
-
Notable Analyst Rating Changes 10/23: (CHKP) (MNI) (YHOO) Upgraded; (NOK) (ARIA) (BTU) Downgraded
-
Pre-Open Movers 10/01: (CRDN) (FONR) (MTG) Higher; (JAKK) (ALU) (RTN) Lower (more...)
-
Notable Analyst Rating Changes 09/10: (RF) (ARIA) (S) Upgraded; (WFC) (STX) (IP) Downgraded
-
RBC Capital Starts ARIAD Pharmaceuticals (ARIA) at Outperform

